![Karen Chapman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Karen B. Chapman is the founder of Origen Therapeutics, Inc. Dr. Chapman was Vice President-Research at Insight Molecular Diagnostics, Inc. from 2011 to 2017.
Dr. Chapman completed graduate studies at Cornell University and earned a doctorate from The Johns Hopkins University School of Medicine in 1991.
Eerdere bekende functies van Karen Chapman
| Bedrijven | Functie | Einde |
|---|---|---|
| INSIGHT MOLECULAR DIAGNOSTICS INC. | Hoofd Techniek/Wetenschap/O&O | 22-03-2017 |
Origen Therapeutics, Inc.
 Origen Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company, develops products from avian transgenic animal technology | Oprichter | - |
Opleiding van Karen Chapman
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
19
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Origen Therapeutics, Inc.
Origen Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company, develops products from avian transgenic animal technology | Health Technology |
OncoCyte Corp.
 OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
